Nutex Health, Inc. (NASDAQ: NUTX) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $1.2B. The Maz Rating grades it against the other companies in its sector.
Nutex Health, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $172.01, Nutex Health, Inc. trades at 7.3x trailing earnings, 1.5x sales and 2.7x book value, with an EV/EBITDA of 3.9. Over the last twelve months it generated about $791M of revenue and $162M of net income. It runs a gross margin of 47.8%, an operating margin of 39.0% and a net margin of 20.7%. It shows return on equity of 43.8%, return on invested capital of 27.1% and a free cash flow yield of 21.1%. On the balance sheet: a debt-to-equity ratio of 0.84 and a current ratio of 4.76. Over the past 52 weeks the share price ranged from $83.99 to $226.16, with a beta of 2.00.
Nutex Health, Inc. does not currently pay a dividend.
5 Wall Street analyst ratings cover the stock: 5 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.